The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Organ Transplantation Immunosuppressive Drug Market Research Report 2025
Synopsis
The global Organ Transplantation Immunosuppressive Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Organ Transplantation Immunosuppressive Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Organ Transplantation Immunosuppressive Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Organ Transplantation Immunosuppressive Drug in Kidney Transplant is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Organ Transplantation Immunosuppressive Drug include AbbVie, Allergan Plc, Astellas Pharma, Bristol-Myers Squibb Company, Roche, GlaxoSmithKline plc, Novartis AG, Pfizer and Sanofi S.A., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Organ Transplantation Immunosuppressive Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Transplantation Immunosuppressive Drug.
Report Scope
The Organ Transplantation Immunosuppressive Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Organ Transplantation Immunosuppressive Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organ Transplantation Immunosuppressive Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Allergan Plc
Astellas Pharma
Bristol-Myers Squibb Company
Roche
GlaxoSmithKline plc
Novartis AG
Pfizer
Sanofi S.A.
Veloxis Pharmaceuticals A/S
Segment by Type
Calcineurin Inhibitors
Antiproliferative Agents
mTOR Inhibitors
Antibodies
Steroids
Segment by Application
Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lungs Transplant
Others Transplant
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organ Transplantation Immunosuppressive Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Organ Transplantation Immunosuppressive Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Organ Transplantation Immunosuppressive Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Organ Transplantation Immunosuppressive Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Organ Transplantation Immunosuppressive Drug in Kidney Transplant is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Organ Transplantation Immunosuppressive Drug include AbbVie, Allergan Plc, Astellas Pharma, Bristol-Myers Squibb Company, Roche, GlaxoSmithKline plc, Novartis AG, Pfizer and Sanofi S.A., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Organ Transplantation Immunosuppressive Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Transplantation Immunosuppressive Drug.
Report Scope
The Organ Transplantation Immunosuppressive Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Organ Transplantation Immunosuppressive Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organ Transplantation Immunosuppressive Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Allergan Plc
Astellas Pharma
Bristol-Myers Squibb Company
Roche
GlaxoSmithKline plc
Novartis AG
Pfizer
Sanofi S.A.
Veloxis Pharmaceuticals A/S
Segment by Type
Calcineurin Inhibitors
Antiproliferative Agents
mTOR Inhibitors
Antibodies
Steroids
Segment by Application
Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lungs Transplant
Others Transplant
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organ Transplantation Immunosuppressive Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organ Transplantation Immunosuppressive Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Calcineurin Inhibitors
1.2.3 Antiproliferative Agents
1.2.4 mTOR Inhibitors
1.2.5 Antibodies
1.2.6 Steroids
1.3 Market by Application
1.3.1 Global Organ Transplantation Immunosuppressive Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Kidney Transplant
1.3.3 Bone Marrow Transplant
1.3.4 Liver Transplant
1.3.5 Heart Transplant
1.3.6 Lungs Transplant
1.3.7 Others Transplant
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organ Transplantation Immunosuppressive Drug Market Perspective (2019-2030)
2.2 Organ Transplantation Immunosuppressive Drug Growth Trends by Region
2.2.1 Global Organ Transplantation Immunosuppressive Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Organ Transplantation Immunosuppressive Drug Historic Market Size by Region (2019-2024)
2.2.3 Organ Transplantation Immunosuppressive Drug Forecasted Market Size by Region (2025-2030)
2.3 Organ Transplantation Immunosuppressive Drug Market Dynamics
2.3.1 Organ Transplantation Immunosuppressive Drug Industry Trends
2.3.2 Organ Transplantation Immunosuppressive Drug Market Drivers
2.3.3 Organ Transplantation Immunosuppressive Drug Market Challenges
2.3.4 Organ Transplantation Immunosuppressive Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organ Transplantation Immunosuppressive Drug Players by Revenue
3.1.1 Global Top Organ Transplantation Immunosuppressive Drug Players by Revenue (2019-2024)
3.1.2 Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Players (2019-2024)
3.2 Global Organ Transplantation Immunosuppressive Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Organ Transplantation Immunosuppressive Drug Revenue
3.4 Global Organ Transplantation Immunosuppressive Drug Market Concentration Ratio
3.4.1 Global Organ Transplantation Immunosuppressive Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organ Transplantation Immunosuppressive Drug Revenue in 2023
3.5 Organ Transplantation Immunosuppressive Drug Key Players Head office and Area Served
3.6 Key Players Organ Transplantation Immunosuppressive Drug Product Solution and Service
3.7 Date of Enter into Organ Transplantation Immunosuppressive Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Organ Transplantation Immunosuppressive Drug Breakdown Data by Type
4.1 Global Organ Transplantation Immunosuppressive Drug Historic Market Size by Type (2019-2024)
4.2 Global Organ Transplantation Immunosuppressive Drug Forecasted Market Size by Type (2025-2030)
5 Organ Transplantation Immunosuppressive Drug Breakdown Data by Application
5.1 Global Organ Transplantation Immunosuppressive Drug Historic Market Size by Application (2019-2024)
5.2 Global Organ Transplantation Immunosuppressive Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Organ Transplantation Immunosuppressive Drug Market Size (2019-2030)
6.2 North America Organ Transplantation Immunosuppressive Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Organ Transplantation Immunosuppressive Drug Market Size by Country (2019-2024)
6.4 North America Organ Transplantation Immunosuppressive Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organ Transplantation Immunosuppressive Drug Market Size (2019-2030)
7.2 Europe Organ Transplantation Immunosuppressive Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Organ Transplantation Immunosuppressive Drug Market Size by Country (2019-2024)
7.4 Europe Organ Transplantation Immunosuppressive Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size (2019-2030)
8.2 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Organ Transplantation Immunosuppressive Drug Market Size (2019-2030)
9.2 Latin America Organ Transplantation Immunosuppressive Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Organ Transplantation Immunosuppressive Drug Market Size by Country (2019-2024)
9.4 Latin America Organ Transplantation Immunosuppressive Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size (2019-2030)
10.2 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Organ Transplantation Immunosuppressive Drug Introduction
11.1.4 AbbVie Revenue in Organ Transplantation Immunosuppressive Drug Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Allergan Plc
11.2.1 Allergan Plc Company Detail
11.2.2 Allergan Plc Business Overview
11.2.3 Allergan Plc Organ Transplantation Immunosuppressive Drug Introduction
11.2.4 Allergan Plc Revenue in Organ Transplantation Immunosuppressive Drug Business (2019-2024)
11.2.5 Allergan Plc Recent Development
11.3 Astellas Pharma
11.3.1 Astellas Pharma Company Detail
11.3.2 Astellas Pharma Business Overview
11.3.3 Astellas Pharma Organ Transplantation Immunosuppressive Drug Introduction
11.3.4 Astellas Pharma Revenue in Organ Transplantation Immunosuppressive Drug Business (2019-2024)
11.3.5 Astellas Pharma Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Detail
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Organ Transplantation Immunosuppressive Drug Business (2019-2024)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Organ Transplantation Immunosuppressive Drug Introduction
11.5.4 Roche Revenue in Organ Transplantation Immunosuppressive Drug Business (2019-2024)
11.5.5 Roche Recent Development
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Company Detail
11.6.2 GlaxoSmithKline plc Business Overview
11.6.3 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Introduction
11.6.4 GlaxoSmithKline plc Revenue in Organ Transplantation Immunosuppressive Drug Business (2019-2024)
11.6.5 GlaxoSmithKline plc Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Detail
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Organ Transplantation Immunosuppressive Drug Introduction
11.7.4 Novartis AG Revenue in Organ Transplantation Immunosuppressive Drug Business (2019-2024)
11.7.5 Novartis AG Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Organ Transplantation Immunosuppressive Drug Introduction
11.8.4 Pfizer Revenue in Organ Transplantation Immunosuppressive Drug Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Sanofi S.A.
11.9.1 Sanofi S.A. Company Detail
11.9.2 Sanofi S.A. Business Overview
11.9.3 Sanofi S.A. Organ Transplantation Immunosuppressive Drug Introduction
11.9.4 Sanofi S.A. Revenue in Organ Transplantation Immunosuppressive Drug Business (2019-2024)
11.9.5 Sanofi S.A. Recent Development
11.10 Veloxis Pharmaceuticals A/S
11.10.1 Veloxis Pharmaceuticals A/S Company Detail
11.10.2 Veloxis Pharmaceuticals A/S Business Overview
11.10.3 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Introduction
11.10.4 Veloxis Pharmaceuticals A/S Revenue in Organ Transplantation Immunosuppressive Drug Business (2019-2024)
11.10.5 Veloxis Pharmaceuticals A/S Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
